Synapse

← Adrian L. Harris

Papers by Adrian L. Harris

Page 4 · newest first

  1. The pH low insertion peptide pHLIP Variant 3 as a novel marker of acidic malignant lesionsJournal of Media Literacy Education · 2015
  2. Metronomic vinorelbine: Anti-angiogenic activity in vitro in normoxic and severe hypoxic conditions, and severe hypoxia-induced resistance to its anti-proliferative effect with reversal by Akt inhibitionInternational Journal of Oncology · 2015
  3. Neoadjuvant Window Studies of Metformin and Biomarker Development for Drugs Targeting Cancer MetabolismJNCI Monographs · 2015
  4. International Expert Consensus on Primary Systemic Therapy in the Management of Early Breast Cancer: Highlights of the Fifth Symposium on Primary Systemic Therapy in the Management of Operable Breast Cancer, Cremona, Italy (2013)JNCI Monographs · 2015
  5. Effect of Primary Letrozole Treatment on Tumor Expression of mTOR and HIF-1 and Relation to Clinical ResponseJNCI Monographs · 2015
  6. The Role of Histone Demethylase KDM4B in Myc Signaling in NeuroblastomaJNCI Journal of the National Cancer Institute · 2015
  7. A Phase I First-in-Human Study of Enoticumab (REGN421), a Fully Human Delta-like Ligand 4 (Dll4) Monoclonal Antibody in Patients with Advanced Solid TumorsClinical Cancer Research · 2015
  8. Metabolic and hypoxic adaptation to anti‐angiogenic therapy: a target for induced essentialityEMBO Molecular Medicine · 2015
  9. Combining lapatinib and pertuzumab to overcome lapatinib resistance due to NRG1-mediated signalling in HER2-amplified breast cancerOncotarget · 2015
  10. A small molecule targeting ALK1 prevents Notch cooperativity and inhibits functional angiogenesisAngiogenesis · 2015
  11. Acetyl-CoA Synthetase 2 Promotes Acetate Utilization and Maintains Cancer Cell Growth under Metabolic StressENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) · 2015
  12. Imaging tumour hypoxia with positron emission tomographyBritish Journal of Cancer · 2014
  13. Hypoxia induces a lipogenic cancer cell phenotype via HIF1α-dependent and -independent pathwaysOncotarget · 2014
  14. Combination of letrozole, metronomic cyclophosphamide and sorafenib is well-tolerated and shows activity in patients with primary breast cancerBritish Journal of Cancer · 2014
  15. Tumor hypoxia induces nuclear paraspeckle formation through HIF-2α dependent transcriptional activation of NEAT1 leading to cancer cell survivalOncogene · 2014
  16. A review of ELTD1, a pro-angiogenic adhesion GPCRBiochemical Society Transactions · 2014
  17. Molecular Pathways: Translational and Therapeutic Implications of the Notch Signaling Pathway in CancerClinical Cancer Research · 2014
  18. Autophagy and lysosomal related protein expression patterns in human glioblastomaCancer Biology & Therapy · 2014
  19. Targeting tumour hypoxia to prevent cancer metastasis. From biology, biosensing and technology to drug development: the METOXIA consortiumJournal of Enzyme Inhibition and Medicinal Chemistry · 2014
  20. Fatty Acid Uptake and Lipid Storage Induced by HIF-1α Contribute to Cell Growth and Survival after Hypoxia-ReoxygenationCell Reports · 2014
  21. Intracellular Carbonic Anhydrase Activity Sensitizes Cancer Cell pH Signaling to Dynamic Changes in CO2 Partial PressureJournal of Biological Chemistry · 2014
  22. Informed Consent, Biobank Research, and LocalityJournal of Empirical Research on Human Research Ethics · 2014
  23. Fatty Acid-binding Protein 4, a Point of Convergence for Angiogenic and Metabolic Signaling Pathways in Endothelial CellsJournal of Biological Chemistry · 2014
  24. The Hematopoietic Chemokine CXCL12 Promotes Integration of Human Endothelial Colony Forming Cell–Derived Cells into Immature Vessel NetworksStem Cells and Development · 2014
  25. COX-2 expression is predictive for early relapse and aromatase inhibitor resistance in patients with ductal carcinoma in situ of the breast, and is a target for treatmentBritish Journal of Cancer · 2014
  26. ADAM10 mediates trastuzumab resistance and is correlated with survival in HER2 positive breast cancerOncotarget · 2014
  27. Nuclear HER4 mediates acquired resistance to trastuzumab and is associated with poor outcome in HER2 positive breast cancerOncotarget · 2014
  28. Prospective neoadjuvant analysis of PET imaging and mechanisms of resistance to Trastuzumab shows role of HIF1 and autophagyBritish Journal of Cancer · 2014
  29. TRAP1 Regulates Proliferation, Mitochondrial Function, and Has Prognostic Significance in NSCLCMolecular Cancer Research · 2014
  30. Proline-Hydroxylated Hypoxia-Inducible Factor 1α (HIF-1α) Upregulation in Human TumoursPLoS ONE · 2014
  31. The chemistry, physiology and pathology of pH in cancerPhilosophical Transactions of the Royal Society B Biological Sciences · 2014
  32. Integrated analysis of microRNA and mRNA expression and association with HIF binding reveals the complexity of microRNA expression regulation under hypoxiaMolecular Cancer · 2014
  33. Role of carbohydrate response element-binding protein (ChREBP) in generating an aerobic metabolic phenotype and in breast cancer progressionBritish Journal of Cancer · 2013
  34. Extensive regulation of the non‐coding transcriptome by hypoxia: role of HIF in releasing paused RNA pol2EMBO Reports · 2013
  35. Scarring, stem cells, scaffolds and skin repairJournal of Tissue Engineering and Regenerative Medicine · 2013
  36. The G-Protein–Coupled Receptor CLR Is Upregulated in an Autocrine Loop with Adrenomedullin in Clear Cell Renal Cell Carcinoma and Associated with Poor PrognosisClinical Cancer Research · 2013
  37. A Core Human Primary Tumor Angiogenesis Signature Identifies the Endothelial Orphan Receptor ELTD1 as a Key Regulator of AngiogenesisCancer Cell · 2013
  38. Vessel co‐option in primary human tumors and metastases: an obstacle to effective anti‐angiogenic treatment?Cancer Medicine · 2013
  39. A 26-Gene Hypoxia Signature Predicts Benefit from Hypoxia-Modifying Therapy in Laryngeal Cancer but Not Bladder CancerClinical Cancer Research · 2013
  40. Hypoxia regulates FGFR3 expression via HIF-1α and miR-100 and contributes to cell survival in non-muscle invasive bladder cancerBritish Journal of Cancer · 2013
  41. The use of bio‐metal concentrations correlated with clinical prognostic factors to assess human breast tissuesX-Ray Spectrometry · 2013
  42. Necrosis predicts benefit from hypoxia-modifying therapy in patients with high risk bladder cancer enrolled in a phase III randomised trialRadiotherapy and Oncology · 2013
  43. Increased pathological complete response rate after a long-term neoadjuvant letrozole treatment in postmenopausal oestrogen and/or progesterone receptor-positive breast cancerBritish Journal of Cancer · 2013
  44. P21-Activated Kinase 1 (PAK1) as a Therapeutic Target in BRAF Wild-Type MelanomaJNCI Journal of the National Cancer Institute · 2013
  45. miR-210 is a target of hypoxia-inducible factors 1 and 2 in renal cancer, regulates ISCU and correlates with good prognosisBritish Journal of Cancer · 2013
  46. Sterol regulatory element binding protein-dependent regulation of lipid synthesis supports cell survival and tumor growthCancer & Metabolism · 2013
  47. Molecular Basis for Jagged-1/Serrate Ligand Recognition by the Notch ReceptorJournal of Biological Chemistry · 2013
  48. Overexpression of LC3A autophagy protein in follicular and diffuse large B-cell lymphomasHematology/Oncology and Stem Cell Therapy · 2013
  49. Inhibition of carbonic anhydrase activity modifies the toxicity of doxorubicin and melphalan in tumour cellsin vitroJournal of Enzyme Inhibition and Medicinal Chemistry · 2012
  50. Clinical Imaging of Tumor AngiogenesisFuture Oncology · 2012